Author:
Hung Le Van Manh,Ngo Hieu Trong,Van Pham Phuc
Publisher
Springer International Publishing
Reference100 articles.
1. Ahmed, N., et al. (2015). Human epidermal growth factor receptor 2 (HER2)–specific chimeric antigen receptor–modified T cells for the immunotherapy of HER2-positive sarcoma. Journal of Clinical Oncology, 33(15), 1688.
2. Allison, J. P., Mcintyre, B. W., & Bloch, D. (1982). Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody. The Journal of Immunology, 129(5), 2293–2300.
3. Borghaei, H., Smith, M. R., & Campbell, K. S. (2009). Immunotherapy of cancer. European Journal of Pharmacology, 625(1–3), 41–54.
4. Bray, F., et al. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394–424.
5. Caruana, I., et al. (2015). Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes. Nature Medicine, 21(5), 524.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献